Epstein Becker Green was engaged to provide antitrust guidance and advice to its health system client in its integration with another health system to form a new $13 billion health system. The firm assisted the client in successfully navigating an arduous Federal Trade Commission review process that was focused, in part, on novel antitrust theories.